KaydedilenlerDerginizi ekleyin

Dergiler / International Journal of Secondary Metabolite / 2026 / Volume: 7 Issue: 2

Investigation of Some Corticosteroids as Glutathione Reductase Inhibitor

Esra Şentürk(AĞRI İBRAHİM ÇEÇEN ÜNİVERSİTESİ, SAĞLIK YÜKSEKOKULU)0000-0003-4378-7678
Murat Şentürk(AGRI IBRAHIM CECEN UNIVERSITY, FACULTY OF PHARMACY, PHARMACEUTICS PR.)0000-0002-9638-2896
Sayfa
—
Yayın Tarihi
2020-06-13
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

These corticosteroids exhibit very potent inhibitory activity against GR enzyme at low micromolar concentrations when compared to well-known GRIs.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:The detection of glutathione reductase inhibitors (GRIs) has recently become very popular due to their use as malarial and cancer drugs.
📊
Temel Bulgular & Veri:IC50 values were determined by drawing % activity-[I] graphs for these corticosteroids showing inhibition effects.
💡
Sonuç & Katkı:These corticosteroids exhibit very potent inhibitory activity against GR enzyme at low micromolar concentrations when compared to well-known GRIs.
🔬Tür:Research Article
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Steroid · Glutathione reductase · Inhibition

Özet

The detection of glutathione reductase inhibitors (GRIs) has recently become very popular due to their use as malarial and cancer drugs. Today, steroidal compounds have several clinical roles due to their potent immunomodulating and anti-inflammatory properties. In this study, GR inhibitory capacity of some corticosteroids (dexamethasone, prednisolone and methylprednisolone) has been reported. Amongst these steroidal molecules dexamethasone showed the weakest inhibitory effect on GR enzyme. IC50 values were determined by drawing % activity-[I] graphs for these corticosteroids showing inhibition effects. These corticosteroids have inhibition ranging micromolar for GR with IC50 values. These corticosteroids exhibit very potent inhibitory activity against GR enzyme at low micromolar concentrations when compared to well-known GRIs.

Abstract

The detection of glutathione reductase inhibitors (GRIs) has recently become very popular due to their use as malarial and cancer drugs. Today, steroidal compounds have several clinical roles due to their potent immunomodulating and anti-inflammatory properties. In this study, GR inhibitory capacity of some corticosteroids (dexamethasone, prednisolone and methylprednisolone) has been reported. Amongst these steroidal molecules dexamethasone showed the weakest inhibitory effect on GR enzyme. IC50 values were determined by drawing % activity-[I] graphs for these corticosteroids showing inhibition effects. These corticosteroids have inhibition ranging micromolar for GR with IC50 values. These corticosteroids exhibit very potent inhibitory activity against GR enzyme at low micromolar concentrations when compared to well-known GRIs.

🔖

Bu Makaleye Atıf Yap

Şentürk, E., Şentürk, M. (2020). Investigation of Some Corticosteroids as Glutathione Reductase Inhibitor. International Journal of Secondary Metabolite, Volume: 7 Issue: 2. https://doi.org/10.21448/ijsm.693816

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (21)

  1. Karplus, P.A., Schulz, G.E. (1987). Refined structure of glutathione reductase at 1.54 A resolution. J. Mol. Biol., 195, 701-729. doi:https://doi.org/10.1016/0022-2836(87)9019-4
  2. Karplus, P.A., Pai, E.F., Schulz, G.E. (1989). A crystallographic study of the glutathione binding site of glutathione reductase at 0.3 nm resolution. Eur. J. Biochem., 178, 693-703. doi:https://doi.org/10.1111/j.1432-1033.1989.tb14500.x
  3. Kocaoglu, E., Talaz, O., Cavdar, H., Senturk, M., Supuran, C.T., Ekinci, D. (2019). Determination of the inhibitory effects of N-methylpyrrole derivatives on glutathione reductase enzyme. J. Enzym. Inhib. Med. Chem., 34, 51 54. doi:https://doi.org/10.1080/14756366.2018.1520228
  4. Yu, J., Zhou, C.Z. (2007). Crystal structure of glutathione reductase Glr1 from the yeast Saccharomyces cerevisiae. Proteins, 68, 972-979. doi:https://doi.org/10.1002/prot.21354
  5. Balaydin, H.T., Ozil, M., Senturk, M. (2018). Synthesis and glutathione reductase inhibitory properties of 5-methyl-2,4-dihydro-3H-1,2,4-triazol-3-one’s aryl schiff base derivatives. Archive der Pharm., 351, e1800086. doi:10.1002/ardp.201800086
  6. Couto, N., Wood, J., Barber, J. (2016). The role of glutathione reductase and related enzymes on cellular redox homoeostasis network. Free Rad. Biol. Med., 95, 27-42. doi:https://doi.org/10.1016/j.freeradbiomed.2016.02.028
  7. Balendiran, G.K., Dabur, R., Fraser, D. (2004). The role of glutathione in cancer. Cell Biochem. Funct., 22, 343-352. doi:10.1002/cbf.1149
  8. Traverso, N., Ricciarelli, R., Nitti, M., Marengo, B., Furfaro, A.L., Pronzato, M.A., Marinari, U.M., Domenicotti, C. (2013). Role of glutathione in cancer progression and chemoresistance. Oxid. Med. Cell. Longev., 2013. doi:https://doi.org/10.1155/2013/972913
  9. Williams, D.M. (2018). Clinical pharmacology of corticosteroids. Respir Care, 63, 655-670. doi:https://doi.org/10.4187/respcare.06314
  10. Stewart, P.M., Krone, N.P. (2011). The adrenal cortex. In: Melmed, S., Polonsky, K., Larsen, P.R., Kronenberg, H. eds. Williams Textbook of Endocrinology. 12th ed. Philadelphia, PA: Saunders-USA. ISBN: 9781437703245.
  11. Beutler, E. (1984). Red Cell Metabolism. A Manual of Biochemical Methods. Grune and Stratton Inc, Orlando. ISBN: 0808916726 9780808916727.
  12. Boehme, C.C., Arscott, L.D., Becker, K., Schirmer, R.H., Williams, C.H. (2000). Kinetic characterization of glutathione reductase from the malarial parasite Plasmodium falciparum comparison with the human enzyme. J. Biol. Chem., 275, 37317-37323. doi:10.1074/jbc.M007695200
  13. Becker, K., Rahlfs, S., Nickel, C., Schirmer, R.H. (2003). Glutathione-function and metabolism in the malarial parasite Plasmodium falciparum. Biol. Chem., 384, 551-566. doi:https://doi.org/10.1515/BC.2003.063
  14. Seefeldt, T., Zhao, Y., Chen, W., Raza, A.S., Carlson, L., Herman, J., Stoebner, A., Hanson, S., Foll, R., Guan, X.M. (2009). Characterization of a novel dithiocarbamate glutathione reductase inhibitor and its use as a tool to modulate intracellular glutathione. J Biol Chem., 284, 2729-2737. doi:10.1074/jbc.M802683200
  15. Grellier, P., Sarlauskas, J., Anusevicius, Z., Maroziene, A., Houee-Levin, C., Schrevel, J., Cenas, N. (2001). Antiplasmodial activity of nitroaromatic and quinoidal compounds: Redox potential vs inhibition of erythrocyte glutathione reductase. Arch. Biochem. Biophys., 393, 199-206. doi:https://doi.org/10.1006/abbi.2001.2487
  16. Senturk, M., Kufrevioglu, O.I., Ciftci, M. (2008). Effects of some antibiotics on human erythrocyte glutathione reductase: An in vitro study. J. Enzym. Inhib. Med. Chem. 23, 144-148. doi:https://doi.org/10.1080/14756360701342581
  17. Senturk, E., Urçar, H., Senturk, M., Yildirim, S., Gul, M., (2016). Bovine liver tissue on glutathione reductase enzyme determination of effects of thiamine, tyrosine, dopamine and adrenaline. Acta Physiol., 218, 58.
  18. Dalmizrak, O., Terali, K., Asuquo, E.B., Ogus, I.H., Ozer, N. (2019). The relevance of glutathione reductase ınhibition by fluoxetine to human health and disease: Insights derived from a combined kinetic and docking study. Protein J., 38, 515-524. doi:10.1007/s10930-019-09834-7
  19. Cakmak, R., Durdagi, S., Ekinci, D., Senturk, M., Topal, G. (2011). Design, synthesis and biological evaluation of novel nitroaromatic compounds as potent glutathione reductase inhibitors. Bioorg Med Chem Lett., 21, 5398 5402. doi:https://doi.org/10.1016/j.ejmech.2009.03.006
  20. Couto, N., Wood, J., Barber, J. (2016). The role of glutathione reductase and related enzymes on cellular redox homoeostasis network. Free Rad. Biol. Med., 95, 27-42. doi:http://dx.doi.org/10.1016/j.freeradbiomed.2016.02.028
  21. Benhar, M., Shytaj, I.L., Stamler, J.S., Savarino, A. (2016). Dual targeting of the thioredoxin and glutathione systems in cancer and HIV. J. Clin. Invest., 126, 1630-1639. doi:10.1172/JCI85339